» Authors » David Simonyan

David Simonyan

Explore the profile of David Simonyan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 357
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Gagnon B, Murphy J, Simonyan D, Penafuerte C, Sirois J, Chasen M, et al.
J Cachexia Sarcopenia Muscle . 2024 Mar; 15(3):1041-1053. PMID: 38481033
Background: The interdependence of cytokines and appetite-modifying hormones implicated in cancer anorexia-cachexia syndrome (CACS) remains unclear. This study aimed to regroup these cytokines and hormones into distinct inflammatory (or non-inflammatory)...
12.
Nguyen Van Long F, Valcourt-Gendron D, Caron P, Rouleau M, Villeneuve L, Simonyan D, et al.
Clin Transl Med . 2023 Dec; 13(12):e1442. PMID: 38037464
Background: Metabolic dependencies of chronic lymphocytic leukaemia (CLL) cells may represent new personalized treatment approaches in patients harbouring unfavourable features. Methods: Here, we used untargeted metabolomics and lipidomics analyses to...
13.
Samman K, Le C, Burstein B, Rehimini S, Grenier A, Bertrand-Bureau C, et al.
CJEM . 2023 Nov; 26(1):31-39. PMID: 38032525
Objectives: The primary objective of this study was to describe and compare the motivation of parents/guardians to bring children with low-acuity conditions to a tertiary-care pediatric emergency department (ED) versus...
14.
Marc I, Lavoie P, McPhee A, Collins C, Simonyan D, Pronovost E, et al.
BMJ Open . 2023 Jul; 13(7):e076223. PMID: 37518076
Introduction: Severe bronchopulmonary dysplasia (BPD) is a well-known factor consistently associated with impaired cognitive outcomes. Regarding reported benefits on long-term neurodevelopmental outcomes, the potential adverse effects of high-dose docosahexaenoic acid...
15.
Fougere H, Greffard K, Guillot M, Rudkowska I, Pronovost E, Simonyan D, et al.
Lipids Health Dis . 2023 Jul; 22(1):103. PMID: 37452341
Oxylipins are derived from enzymatic and non-enzymatic oxidation of n-3 and n-6 long-chain polyunsaturated fatty acids. They are known to be involved in inflammatory processes. The aim of this study...
16.
Molina O, LaRue H, Simonyan D, Hovington H, Tetu B, Fradet V, et al.
Front Immunol . 2023 Jul; 14:1205266. PMID: 37435060
Introduction: Prostate cancer (PCa) shows considerable variation in clinical outcomes between individuals with similar diseases. The initial host-tumor interaction as assessed by detailed analysis of tumor infiltrating immune cells within...
17.
Dahmani C, Caron P, Simonyan D, Turcotte V, Gregoire J, Plante M, et al.
Front Endocrinol (Lausanne) . 2023 Jun; 14:1156680. PMID: 37288302
Context: Recent evidence support that androgens play an important role in the etiology of endometrial cancer (EC). Adrenal-derived 11-oxygenated androgens are highly potent agonists of the androgen receptor (AR), comparable...
18.
Series T, Guillot M, Angoa G, Pronovost E, Ndiaye A, Mohamed I, et al.
J Pediatr . 2023 Jun; 260:113531. PMID: 37268036
Objective: To determine how neonatal growth velocity affects the association between birth weight and neurodevelopmental outcomes in infants born preterm. Study Design: This study is a secondary analysis of the...
19.
Marx T, Moore L, Talbot D, Guertin J, Lachapelle P, Blais S, et al.
CJEM . 2023 Apr; 25(5):394-402. PMID: 37004679
Objectives: Our aim was to compare some of the health outcomes and costs associated with value of care in emergency departments (ED) and walk-in clinics for ambulatory patients presenting with...
20.
You Y, Simonyan D, Bureau A, Gagnon E, Albert C, Guertin J, et al.
Bone Rep . 2023 Mar; 18:101670. PMID: 36915391
Purpose: Paget's disease of bone (PDB) is a focal metabolic bone disorder characterized by an increased bone remodeling. Fifteen to 40 % of PDB patients have a familial form with...